Tima le, DO
Physical Medicine & Rehabilitation · Phoenix, AZNPI 1952532715
Payments from drug & device makers
What this record shows
Abbott accounts for 81.1% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2021 at $1,934 and has fallen 93.2% since, to $131 in 2025.
Across 68 payments — averaging $45.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$3K
- Medtronic$143
- Relievant Medsystems, Inc.$113
- Boston Scientific$65
- Nalu Medical, Inc.$63
- Scilex Pharmaceuticals Inc.$56
- plus $150 from 5 others
What the payments were for
- Travel & lodging$1,44546%
- Food & beverage$1,67454%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 43 | $2,529 |
| Medtronic(2 entities) | 6 | $143 |
| Relievant Medsystems, Inc. | 1 | $113 |
| Boston Scientific | 3 | $65 |
| Nalu Medical, Inc. | 3 | $63 |
| Scilex Pharmaceuticals Inc. | 3 | $56 |
| Arbor Pharmaceuticals, Inc. | 4 | $54 |
| Assertio Therapeutics, Inc. | 2 | $38 |
| Averitas Pharma Inc. | 1 | $26 |
| Otto Bock Healthcare LP | 1 | $19 |
| Team_makena_llc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Proclaim IPG$1,021
- Proclaim DRG IPG$534
- Proclaim Family of SCS IPGs$440
- Intracept$225
How this compares
$3,119 in reported general payments places this provider in the 85th percentile of 162 physical medicine & rehabilitation providers in Arizona.
See all physical medicine & rehabilitation providers in Arizona →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 167 | $2,309 |
| Etodolac | 51 | $1,758 |
| Pregabalin | 91 | $1,724 |
| Tizanidine Hcl | 34 | $735 |
| Celecoxib | 20 | $686 |
| Duloxetine Hcl | 14 | $309 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 28 | $276 |
| Methocarbamol | 21 | $200 |
| Tramadol Hcl | 16 | $104 |
| Methylprednisolone | 13 | $71 |
| Meloxicam | 28 | $50 |
| Diazepam | 16 | $25 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Phoenix
- Azmi NasserPhoenix$46K
- Christina KwasnicaPhoenix$33K
- Keikhosrow MosallaiePhoenix$11K
- Heather TheobaldPhoenix$9K
- Peter KubitzPhoenix$7K
- Grace MaloneyPhoenix$5K
- Vivek MehtaPhoenix$4K
- Brad SoroskyPhoenix$4K
- Julie HastingsPhoenix$3K
- Kevin LadinPhoenix$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.